Brief: ABVC Biopharma & Biolite Entered Into Definitive Agreement With Oncox Biopharma To Collaborate On Combination Therapy

ABVC Biopharma

24/05/2024 13:31

May 24 (Reuters) - ABVC Biopharma Inc  ABVC.O :
    * ABVC BIOPHARMA- CO & BIOLITE ENTERED INTO DEFINITIVE
AGREEMENT
WITH ONCOX BIOPHARMA TO COLLABORATE ON COMBINATION THERAPY
    * ABVC BIOPHARMA- ABVC & UNIT ARE ELIGIBLE TO RECEIVE
AGGREGATE
LICENSE FEE OF $12.5 MILLION IN FORM OF CASH OR SHARES OF ONCOX
SECURITIES
    * ABVC BIOPHARMA- UNDER TERMS OF DEAL, ABVC GRANTS ONCOX
EXCLUSIVE
RIGHTS FOR ONE OF ABVC’S FOUR PRODUCTS IN ITS ONCOLOGY PIPELINE

Source text for Eikon:  ID:n0001213900-24-046419 
Further company coverage:  ABVC.O 

 ((Reuters.Briefs@thomsonreuters.com;))